Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STAAR SURGICAL CO Director's Dealing 2021

Aug 19, 2021

31996_dirs_2021-08-18_12ed53ec-971e-43ff-a7b2-de3544dbee9c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2021-08-18

Reporting Person: Francese James E (Sr. VP, Comm. Ops., NA, APAC)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-08-18 Common Stock M 5000 $7.52 Acquired 57630 Direct
2021-08-18 Common Stock M 3664 $16.15 Acquired 61294 Direct
2021-08-18 Common Stock M 6336 $29.80 Acquired 67630 Direct
2021-08-18 Common Stock S 15000 $146.91 Disposed 52630 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-08-18 Common Stock Options $7.52 M 5000 Disposed 2026-03-17 Common Stock (5000) Direct
2021-08-18 Common Stock Options $16.15 M 3664 Disposed 2028-03-14 Common Stock (3664) Direct
2021-08-18 Common Stock Options $29.80 M 6336 Disposed 2028-06-13 Common Stock (6336) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.31 to $148.37, inclusive.